BenchlingISO/NSO

Benchling equity calculator: value your options at the latest valuation

Calculate the current value of your Benchling equity using secondary market data and four independent valuation methods. Free, no account required.

Benchling — current market snapshot
Last primary round
$6.1B
Series E · 2021-01
Secondary market
No recent verified signal
Annual revenue (ARR)
$0.1B
+30% YoY
Equity type
ISO/NSO
Strike: $18–$30

Key things to know

  • Benchling is the leading R&D cloud platform for life sciences and biotech.
  • Secondary market implied valuation tracks the latest closed round.
  • IPO possible 2026–2028.
  • Typical strike price range varies by grant year.

Open the calculator

Enter your actual shares, equity type, and strike price. PrivatePulse uses secondary market data and four independent valuation methods to give you a defensible range.

Calculate my Benchling equity →
Free · No account required · Takes 2 minutes

Liquidity outlook for Benchling

No near-term IPO expected. Company likely 2028+ at earliest; patient equity required.

As an option holder, you'll need to exercise your ISO/NSO to own shares. Strike price, exercise cost, and tax treatment (ISO vs NSO) all matter. Model carefully with a CPA.

Frequently asked questions

What is my Benchling equity worth right now?
Benchling's Series E (2021) valued the company at $6B. Secondary market data (Hiive, Forge, Caplight) gives a live read on implied valuation — PrivatePulse tracks this and updates every week. Gross value per option = (secondary share price − your strike price). Multiply by your vested count, then subtract taxes. The PrivatePulse calculator handles all of this automatically.
When will Benchling go public or offer liquidity?
Benchling is at $6.1B — still in an early-to-mid growth stage. An IPO is likely 4–6 years away at minimum. Liquidity before then typically requires a tender offer or secondary sale approved by the company.
What is the Benchling strike price for employee options?
Strike prices at Benchling vary by grant year and cohort. Recent grants typically carry strikes in the $0–$30 range per share. Your grant agreement shows your exact 409A strike. With Benchling now implying ~$6B, the intrinsic value per option is (current secondary price per share − your strike); enter your numbers in the PrivatePulse calculator to see the full picture including AMT and vesting schedule.
What's the difference between Benchling ISOs and NSOs?
Benchling typically grants a mix of Incentive Stock Options (ISOs) and Non-Qualified Stock Options (NSOs). ISOs: exercised spread is not taxed as income — instead it creates an AMT preference item. Long-term capital gains treatment is available if you hold shares 2 years from grant and 1 year from exercise. NSOs: exercised spread is ordinary income immediately — simpler but less tax-efficient. Both types require payment of the strike price to exercise. Use the PrivatePulse calculator to model the after-tax outcome under ISO vs NSO treatment at the current $6B implied valuation.